Results 11 to 20 of about 5,010 (154)
Journal of Diabetes, Volume 15, Issue 12, Page 1081-1094, December 2023., 2023 Highlights Glucagon receptor (GCGR) monoclonal antibody (mAb) improves cardiac function and attenuates microvascular damage in db/db mice. GCGR mAb ameliorates the oxidative stress of cardiac microvascular endothelial cells in diabetic mice. GCGR mAb counteracts the diabetes‐induced upregulation of carnitine palmitoyltransferase 1B, optic atrophy type ...
Peng Wang +6 more
wiley +1 more source
Veterinary Dermatology, Volume 34, Issue 4, Page 327-338, August 2023., 2023 Background – The caninised monoclonal antibody lokivetmab (LKV), directed at interleukin (IL)‐31, is very effective at controlling pruritus in most dogs with atopic dermatitis (AD). However, evidence exists that IL‐31 is not required for the induction of acute allergic skin inflammation, which might explain why this treatment is less efficacious in ...
Chie Tamamoto‐Mochizuki +4 more
wiley +1 more source
Veterinary Dermatology, Volume 32, Issue 5, Page 477-e131, October 2021., 2021 Background – Interleukin (IL)‐31 is an important mediator in canine atopic dermatitis (cAD) and also may be dysregulated in other allergic diseases. Hypothesis/Objectives – To demonstrate the efficacy and safety of lokivetmab (canine anti‐IL‐31 monoclonal antibody) for treatment of pruritus associated with allergic dermatitis in dogs.
Leen Van Brussel +4 more
wiley +1 more source
Veterinary Dermatology, Volume 31, Issue 6, Page 439-e116, December 2020., 2020 Background It has been demonstrated recently that immunoglobulin (Ig)E specific for cross‐reactive carbohydrate determinants (CCD) is present in the serum of allergen‐sensitized dogs and cats, and that these CCD‐specific antibodies might confound serological testing. Hypothesis/Objective The objective was to document the prevalence of CCD detectable in
Kenneth W. Lee +3 more
wiley +1 more source
Veterinary Dermatology, Volume 36, Issue 4, Page 453-461, August 2025.Background – Canine atopic dermatitis (cAD) is a chronic, inflammatory, multifactorial and pruritic disease. The presence of skin barrier impairment (e.g. filaggrin alterations), along with abnormal immune responses, can negatively impact cutaneous barrier function.
Wendie Roldan Villalobos +5 more
wiley +1 more source
Long‐term use of lokivetmab in dogs with atopic dermatitis
Veterinary Dermatology, Volume 35, Issue 6, Page 683-693, December 2024.Background – Lokivetmab, a caninised monoclonal antibody against interleukin (IL)‐31, is an effective treatment for the pruritus associated with canine atopic dermatitis (cAD). Objectives – To investigate the efficacy and safety of lokivetmab during long‐term treatment defined as at least three consecutive lokivetmab injections in atopic dogs under ...
Bettina Kasper +2 more
wiley +1 more source
Construction and preliminary application of human naïve phage antibody library [PDF]
, 2004 治疗性抗体在临床的应用已从30年代的抗血清时代经由80年代后的单克隆抗体时代进入到今天的基因工程抗体时代。目前处于各期临床的生物新药中，基因工程抗体是最多的一类，显示出治疗性抗体具有广阔的临床应用前景，而人源抗体是治疗性抗体的发展趋势。人源性噬菌体抗体库技术解决了人源性单抗来源困难、人体杂交瘤系统低效及鼠单抗的动物源性难题，是分子生物学和免疫学领域中一个强有力的研究手段。本研究从20例未经免疫的健康人的外周血中分离出淋巴细胞，提取总RNA并纯化出mRNA，然后反转录成cDNA ...
李利峰
core
Zhongguo shiyan zhenduanxue, 2016 目的从单克隆抗体水平研究同种异体肾移植受者多反应性抗体与HLA抗体的相关性,探讨多反应性抗体是否为HLA抗体尤其是非供体特异性抗体产生的原因之一。方法从肾移植患者外周血细胞及手术切除的移植肾组织中分离出B淋巴细胞,并于体外永生化培养获得单克隆B细胞,分别检测B细胞分泌的抗体对HLA抗原及凋亡细胞的反应性。结果共获得107个B细胞克隆,检测发现每个B细胞克隆在体外培养过程中均分泌抗体。其中有4个单克隆B细胞分泌的抗体可以与多种HLA抗原发生反应,而这些HLA抗原之间并非都有共用的抗原决定簇。进一步研究发现,
荣春书, 王伟刚, 连鑫, 高宝山
doaj
Preparation and Characterization of Semaphorin3Fc Monoclonal Antibody and the Preliminary Application [PDF]
, 2015 研究背景和目的 抑癌基因发生异常是癌症发生的机制之一。人类基因的很多区域发生改变时可导致细胞失控性生长。Sema3F作为肺癌19个候选抑癌基因之一，是Ⅲ型Semaphorin（即神经导向因子，最初作为Neuropilins的配体在神经系统中发挥排斥神经节轴突和调节神经系统发育的作用）家族的一个成员。目前有研究发现，与正常组织相比Sema3F蛋白在肿瘤细胞中的表达普遍存在下调的趋势，并在血管形成以及肿瘤增殖、凋亡、粘附和转移等中起着负向调节作用。此外，诸多体内或者体外实验已经证明 ...
李哲
core
Preparation and Application of Soluble Human Squamous Cell Carcinoma Antigen Expressed by Escherichia coli [PDF]
, 2017 旨在建立基于大肠杆菌表达系统的高效可溶性表达人鳞状上皮细胞癌抗原(SCCAg)方法,获得具有较好活性的重组SCCAg抗原并应用于建立抗原检测方法; 。基于pGEX-6P-l载体和大肠杆菌E. coli; ER2566菌株开展重组SCCAg抗原可溶性表达纯化方法研究,评价纯化抗原活性,筛选特异性单克隆抗体,初步建立并评价SCCAg抗原检测方法。结果; 显示,pGEX-6P-l载体和E coli; ER2566菌株可用于建立较高效的可溶性表达和纯化SCCAg抗原的方法 ...
刘剑 +9 more
core +1 more source